Clinical Study | Office of Clinical Research

A Double-Blind, Randomized, Two Arm Phase 2 Study Of Nivolumab In Combination With Ipilimumab Versus Nivolumab In Combination With Ipilimumab Placebo

Posted Date: May 15, 2019

Investigator: Trisha Wise-Draper
Type of Study: Drug

The purpose of this study is to compare how well the study drugs works, safety, and tolerability of the combination of two study drugs called nivolumab and ipilimumab in subjects with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

Criteria:

To Be Eligible To Participate In This Study, Patients Must Have Recurrent Or Metastatic Squamous Cel

Keywords:

Ca209-714, Cancer, Head & Neck, Phase 2

For More Information:

Uc Cancer Center
(513) 584-7698
kastla@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List